BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35698287)

  • 1. Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review.
    Chan C; Sekowski V; Zheng B; Li P; Stollery D; Veenstra J; Gillson AM
    J Bronchology Interv Pulmonol; 2023 Jul; 30(3):238-243. PubMed ID: 35698287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
    Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
    Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
    Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
    Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Pleural Space Infections in Patients With Indwelling Pleural Catheters for Active Malignancies.
    Chang CH; Ost DE; Jimenez CA; Saltijeral SN; Eapen GA; Casal RF; Sabath BF; Lin J; Cerrillos E; Nevarez Tinoco T; Grosu HB
    J Bronchology Interv Pulmonol; 2024 Apr; 31(2):155-159. PubMed ID: 37982602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
    Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
    Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
    Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
    JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural Fibrinolytic Therapy in Patients With Nondraining Indwelling Pleural Catheters.
    Vial MR; Ost DE; Eapen GA; Jimenez CA; Morice RC; O'Connell O; Grosu HB
    J Bronchology Interv Pulmonol; 2016 Apr; 23(2):98-105. PubMed ID: 27058711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
    Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
    Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
    Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
    Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
    Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
    Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study.
    Thomas R; Piccolo F; Miller D; MacEachern PR; Chee AC; Huseini T; Yarmus L; Bhatnagar R; Lee HJ; Feller-Kopman D; Maskell NA; Tremblay A; Lee YCG
    Chest; 2015 Sep; 148(3):746-751. PubMed ID: 25742001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixing It Up: Coadministration of tPA/DNase in Complicated Parapneumonic Pleural Effusions and Empyema.
    Bishwakarma R; Shah S; Frank L; Zhang W; Sharma G; Nishi SP
    J Bronchology Interv Pulmonol; 2017 Jan; 24(1):40-47. PubMed ID: 27984384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a complex malignant pleural effusion with 1 mg alteplase instilled through a non-draining indwelling pleural catheter.
    Nik Abeed NN; Faisal M; Ng BH; Ban Yu-Lin A
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33608330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies to manage complicated pleural effusions.
    Safiyeh M; Huang D
    Crit Care; 2012 May; 16(3):312. PubMed ID: 22621656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report.
    Nikoomanesh K; Phan AT; Sond V; Hasan M
    Cureus; 2022 Apr; 14(4):e24373. PubMed ID: 35619869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients.
    Hsu LH; Soong TC; Feng AC; Liu MC
    J Thorac Oncol; 2006 Jun; 1(5):460-7. PubMed ID: 17409900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
    Smith D; Shaw H; Ryder T
    Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
    Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
    J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
    Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
    Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.